Your email has been successfully added to our mailing list.

×
-0.00147058823529422 -0.00147058823529422 -0.00147058823529422 0.0147058823529411 0.179411764705882 0.227941176470588 0.191176470588235 0.230882352941176
Stock impact report

Proteostasis Therapeutics Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Business Update

PROTEOSTASIS THERAPEUTICS (PTI) 
Last proteostasis therapeutics earnings: 3/10 04:36 pm Check Earnings Report
US:NYSE Investor Relations: ir.proteostasis.com/investor-overview
Company Research Source: GlobeNewswire
14-day Study of PTI-801, Company’s Third Generation Corrector, in CF Patients on Background Orkambi® Enrolling Ahead of Schedule; Results from All Three Cohorts Expected Q2'18 Company Announces Additional Study of PTI-428 in CF Subjects on Symdeko™ to Support Path to NDA, with Initial Data Anticipated in Early 2019 Triple Combination CF Study of PTI-428 + PTI-801 + PTI-808 on Track to Initiate in Q2’18; Preliminary Results Anticipated in 2H’18 Initial Data from PTI’s Double Combination Study of PTI-801 and PTI-808 in CF Patients Expected Mid 2018 CAMBRIDGE, Mass., March 14, 2018 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processing, today announced financial results for the fourth quarter and year ended December 31, 2017 and provided a business update.             Show less Read more
Impact Snapshot
Event Time:
PTI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for PTI alerts
Opt-in for
PTI alerts

from News Quantified
Opt-in for
PTI alerts

from News Quantified